1 unchanged sentence
Rule 10b5-1 Plan Elections
−Removed: During the quarter ended June 30, 2024, the following 10b5-1 director and officer trading plan arrangement changes occurred:
−Removed: On May 8, 2024 , David Cordani , Chairman and Chief Executive Officer of The Cigna Group , adopted a 10b5-1 plan.
−Removed: Cordani's plan provides for (i) the sale of shares of The Cigna Group common stock issuable upon vesting of a performance award (the actual number of shares depends on actual performance achieved and may range from 0% to 200% of the 38,323 shares subject to the award at the target level of performance) and (ii) the exercise of vested stock options and the associated sale of up to 59,527 shares of The Cigna Group common stock, in each case through May 5, 2025 .
−Removed: On May 9, 2024 , Michael Triplett , Special Advisor of The Cigna Group , adopted a 10b5-1 plan.
−Removed: Triplett's plan provides for (i) the sale of up to 2,975 shares of The Cigna Group common stock and (ii) the exercise of 7,200 vested stock options and the associated sale of an indeterminable number of shares of The Cigna Group common stock sufficient to satisfy the option exercise price and applicable tax withholding obligations pursuant to a sell-to-cover instruction, in each case through November 8, 2024 .
−Removed: On May 10, 2024 , Nicole Jones , Executive Vice President, Chief Administrative Officer and General Counsel of The Cigna Group , adopted a 10b5-1 plan.
−Removed: Jones' plan provides for (i) the sale of up to 7,000 shares of The Cigna Group common stock, (ii) the sale of shares of The Cigna Group common stock issuable upon vesting of a performance award (the actual number of shares depends on actual performance achieved and may range from 0% to 200% of the 7,026 shares subject to the award at the target level of performance) and (iii) the exercise of vested stock options and the associated sale of up to 8,833 shares of The Cigna Group common stock, in each case through May 5, 2025 .
−Removed: On May 14, 2024 , William DeLaney , Director of The Cigna Group , adopted a 10b5-1 plan.
−Removed: DeLaney's plan provides for the exercise of vested stock options and the associated sale of up to 2,691 shares of The Cigna Group common stock through May 6, 2025 .
−Removed: These trading plans were entered into during an open insider trading window and are intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Securities Exchange Act of 1934 and the Company's policies regarding insider transactions.
+Added: During the quarter ended September 30, 2024, the following 10b5-1 director and officer trading plan arrangement change occurred:
+Added: On September 12, 2024 , Noelle K.
+Added: Eder , Executive Vice President, Global Chief Information Officer of The Cigna Group , adopted a 10b5-1 plan.
+Added: Eder's plan provides for (i) the sale of up to 5,981 shares of The Cigna Group common stock, (ii) the sale of shares of The Cigna Group common stock issuable upon vesting of a performance award (the actual number of shares depends on actual performance achieved and may range from 0% to 200% of the 6,300 shares subject to the award at the target level of performance), and (iii) the exercise of vested stock options and the associated sale of up to 7,026 shares of The Cigna Group common stock, in each case through May 2, 2025.
+Added: This trading plan was entered into during an open insider trading window and is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Securities Exchange Act of 1934 and the Company's policies regarding insider transactions.
INDEX TO EXHIBITS
4 unchanged sentences
Filed by the registrant as Exhibit 3.3 to the Current Report on Form 8-K on February 13, 2023 and incorporated herein by reference.
−Removed: 10.1 Revolving Credit and Letter of Credit Agreement, dated as of April 25, 2024, with the banks named therein, JPMorgan Chase Bank, N.A., as administrative agent, BofA Securities, Inc., Citibank, N.A., Morgan Stanley Senior Funding, Inc.
−Removed: and Wells Fargo Securities, LLC, as joint lead arrangers and joint bookrunners.
−Removed: Filed by the registrant as Exhibit 10.1 to the Current Report on Form 8-K on April 26, 2024 and incorporated herein by reference.
31.1 Certification of Chief Executive Officer of The Cigna Group pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934
6 unchanged sentences
Furnished herewith.
−Removed: 101 The following materials from The Cigna Group's Quarterly Report on Form 10-Q for the quarter ended June 30, 2024, formatted in Inline XBRL (eXtensible Business Reporting Language):
+Added: 101 The following materials from The Cigna Group's Quarterly Report on Form 10-Q for the quarter ended September 30, 2024, formatted in Inline XBRL (eXtensible Business Reporting Language):
(i) the Consolidated Statements of Income;
7 unchanged sentences
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
−Removed: August 1, 2024
+Added: October 31, 2024
THE CIGNA GROUP
2 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.